ConductScience.org, home

Paper8086321

Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.

Cohn JN. Cardiovasc Drugs Ther, 1994. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Treatment of infarct related heart failure: vasodilators other than ACE inhibitors. Papers, record 8086321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8086321

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of infarct related heart failure: vasodilators other than ACE inhibitors.
PubMed
Journal
Cardiovasc Drugs Ther
PubMed
Year
1994
PubMed
Publication types
Editorial, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.06
iCite
Revised in PubMed
2019-09-14
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohn JNJ N

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heart FailureMajor topic
Myocardial InfarctionMajor topic
Vasodilator AgentsMajor topic
Angiotensin-Converting Enzyme Inhibitors
Drug Therapy, Combination
Humans
Ventricular Function, Left

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18500243Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.Circulation1993https://conductscience.org/library/papers/8500243PubMed
22151900Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition.Trans Assoc Am Physicians1990https://conductscience.org/library/papers/2151900PubMed
31732376Hemodynamic, left ventricular structural and hormonal changes after discrete myocardial damage in the dog.J Am Coll Cardiol1992https://conductscience.org/library/papers/1732376PubMed
46337742Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation1983https://conductscience.org/library/papers/6337742PubMed
58500235Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.Circulation1993https://conductscience.org/library/papers/8500235PubMed
6848799Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.Ann Intern Med1977https://conductscience.org/library/papers/848799PubMed
78500245Functional capacity in heart failure. Comparison of methods for assessment and their relation to other indexes of heart failure. The V-HeFT VA Cooperative Studies Group.Circulation1993https://conductscience.org/library/papers/8500245PubMed
8351232Nitrate therapy for congestive heart failure.JAMA1978https://conductscience.org/library/papers/351232PubMed
97424945Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure.Am J Med1980https://conductscience.org/library/papers/7424945PubMed
104855255Treatment of refractory heart failure with infusion of nitroprusside.N Engl J Med1974https://conductscience.org/library/papers/4855255PubMed
11405585Vasodilator therapy of cardiac failure: (first of two parts).N Engl J Med1977https://conductscience.org/library/papers/405585PubMed
122057035A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.N Engl J Med1991https://conductscience.org/library/papers/2057035PubMed
138339411
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Circulation1993https://conductscience.org/library/papers/8339411PubMed
147044086Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.Am J Cardiol1982https://conductscience.org/library/papers/7044086PubMed
151386652
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
N Engl J Med1992https://conductscience.org/library/papers/1386652PubMed
16620563Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.Chest1978https://conductscience.org/library/papers/620563PubMed
172656266Efficacy of felodipine in congestive heart failure.Eur Heart J1989https://conductscience.org/library/papers/2656266PubMed
184609633Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure.Circulation1974https://conductscience.org/library/papers/4609633PubMed
192210153Heart failure: mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention.FASEB J1990https://conductscience.org/library/papers/2210153PubMed
203520315Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.N Engl J Med1986https://conductscience.org/library/papers/3520315PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8086321

GET https://conductscience.org/api/papers/v1/8086321/references?page=2